Medpacto

Company developing ALK-5 kinase inhibitors for treating solid tumors and multiple myeloma

placeSuwon-si, Gyeonggi-do, South Korea calendar_todayFounded 2013 groups62 employees language medpacto.com

Innovation

20 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 393 times.

YearFilings
20151
20166
20174
20184
20194
20208
20214
20224
20235
20247
20253
20262

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital571%
Private equity114%
Accelerator & incubator114%
Coming soon